View in EDS

Safety and Efficacy of Treatment with Dupilumab for up to 2 Years in Infants and Young Children with Atopic Dermatitis.

Saved in:
Bibliographic Details
Title: Safety and Efficacy of Treatment with Dupilumab for up to 2 Years in Infants and Young Children with Atopic Dermatitis.
Authors: Paller AS; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Division of Dermatology, Ann & Robert H. Lurie Children's Hospital, Chicago, IL, USA., Simpson EL; Department of Dermatology, Oregon Health & Science University, Portland, OR, USA., Siegfried EC; Department of Dermatology and Pediatrics, Saint Louis University School of Medicine, St. Louis, MO, USA.; Department of Pediatric Dermatology, Cardinal Glennon Children's Hospital, St. Louis, MO, USA., Cork MJ; Sheffield Children's NIHR Commercial Research Delivery Centre, Sheffield, UK.; Sheffield Dermatology Research, Division of Clinical Medicine, University of Sheffield Medical School, Sheffield, UK., Arkwright PD; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK., Pinter A; Department of Dermatology, University Hospital Frankfurt, Frankfurt am Main, Germany., Deleuran M; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark., Hong HC; Department of Dermatology and Skin Science, University of British Columbia, Surrey, BC, Canada.; Probity Medical Research, Waterloo, ON, Canada., Ma Y; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Bansal A; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Dubost-Brama A; Sanofi, Gentilly, France., Nguyen TV; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA. tien.nguyen2@regeneron.com.
Source: American journal of clinical dermatology [Am J Clin Dermatol] 2026 May; Vol. 27 (3), pp. 611-620. Date of Electronic Publication: 2026 Mar 28.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1888 (Electronic) Linking ISSN: 11750561 NLM ISO Abbreviation: Am J Clin Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41903092
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and Efficacy of Treatment with Dupilumab for up to 2 Years in Infants and Young Children with Atopic Dermatitis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Paller+AS%22">Paller AS</searchLink>; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Division of Dermatology, Ann & Robert H. Lurie Children's Hospital, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Simpson+EL%22">Simpson EL</searchLink>; Department of Dermatology, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Siegfried+EC%22">Siegfried EC</searchLink>; Department of Dermatology and Pediatrics, Saint Louis University School of Medicine, St. Louis, MO, USA.; Department of Pediatric Dermatology, Cardinal Glennon Children's Hospital, St. Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Cork+MJ%22">Cork MJ</searchLink>; Sheffield Children's NIHR Commercial Research Delivery Centre, Sheffield, UK.; Sheffield Dermatology Research, Division of Clinical Medicine, University of Sheffield Medical School, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Arkwright+PD%22">Arkwright PD</searchLink>; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Pinter+A%22">Pinter A</searchLink>; Department of Dermatology, University Hospital Frankfurt, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Deleuran+M%22">Deleuran M</searchLink>; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Hong+HC%22">Hong HC</searchLink>; Department of Dermatology and Skin Science, University of British Columbia, Surrey, BC, Canada.; Probity Medical Research, Waterloo, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Ma+Y%22">Ma Y</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Bansal+A%22">Bansal A</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Dubost-Brama+A%22">Dubost-Brama A</searchLink>; Sanofi, Gentilly, France.<br /><searchLink fieldCode="AU" term="%22Nguyen+TV%22">Nguyen TV</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA. tien.nguyen2@regeneron.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100895290%22">American journal of clinical dermatology</searchLink> [Am J Clin Dermatol] 2026 May; Vol. 27 (3), pp. 611-620. <i>Date of Electronic Publication: </i>2026 Mar 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>100895290 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1888 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211750561%22">11750561 </searchLink><i>NLM ISO Abbreviation: </i>Am J Clin Dermatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41903092
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40257-026-01018-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 611
    Titles:
      – TitleFull: Safety and Efficacy of Treatment with Dupilumab for up to 2 Years in Infants and Young Children with Atopic Dermatitis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Paller AS
      – PersonEntity:
          Name:
            NameFull: Simpson EL
      – PersonEntity:
          Name:
            NameFull: Siegfried EC
      – PersonEntity:
          Name:
            NameFull: Cork MJ
      – PersonEntity:
          Name:
            NameFull: Arkwright PD
      – PersonEntity:
          Name:
            NameFull: Pinter A
      – PersonEntity:
          Name:
            NameFull: Deleuran M
      – PersonEntity:
          Name:
            NameFull: Hong HC
      – PersonEntity:
          Name:
            NameFull: Ma Y
      – PersonEntity:
          Name:
            NameFull: Bansal A
      – PersonEntity:
          Name:
            NameFull: Dubost-Brama A
      – PersonEntity:
          Name:
            NameFull: Nguyen TV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1888
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: American journal of clinical dermatology
              Type: main
ResultId 1